Although inflammatory biomarkers offer prognostic value, primary GTV-CTV margin expansion has a stronger influence on LRFS in ESCC patients undergoing CRT. Further multi-institutional studies are needed to validate these findings and address current study limitations, including single-center design, small sample size and exclusion of in-field recurrences.
Jiang et al. (Mon,) studied this question.